308 related articles for article (PubMed ID: 29265167)
1. Epidemiology and Medication Trends in Patients with Psoriasis: A Nationwide Population-based Cohort Study from Korea.
Han JH; Lee JH; Han KD; Seo HM; Bang CH; Park YM; Lee JY; Park YG
Acta Derm Venereol; 2018 Apr; 98(4):396-400. PubMed ID: 29265167
[TBL] [Abstract][Full Text] [Related]
2. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Medication Pattern Change of Psoriatic Diseases in Taiwan from 2000 to 2013: A Nationwide, Population-based Cohort Study.
Wei JC; Shi LH; Huang JY; Wu XF; Wu R; Chiou JY
J Rheumatol; 2018 Mar; 45(3):385-392. PubMed ID: 29335350
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Prevalence of Psoriasis in Denmark.
Egeberg A; Skov L; Gislason GH; Thyssen JP; Mallbris L
Acta Derm Venereol; 2017 Jul; 97(7):808-812. PubMed ID: 28417141
[TBL] [Abstract][Full Text] [Related]
5. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
Won S; Cho SK; Kim D; Han M; Lee J; Jang EJ; Sung YK; Bae SC
Rheumatol Int; 2018 Apr; 38(4):649-656. PubMed ID: 29302803
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan.
Wang TS; Hsieh CF; Tsai TF
J Dermatol Sci; 2016 Dec; 84(3):340-345. PubMed ID: 27576765
[TBL] [Abstract][Full Text] [Related]
7. Biologic drug survival in Israeli psoriasis patients.
Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
Radner H; Lesperance T; Accortt NA; Solomon DH
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
[TBL] [Abstract][Full Text] [Related]
9. Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
Kamata Y; Minota S
Rheumatol Int; 2018 Apr; 38(4):663-668. PubMed ID: 29204683
[TBL] [Abstract][Full Text] [Related]
10. Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16 545 biologic-naïve patients from the French National Health Insurance database (SNIIRAM).
Sbidian E; Mezzarobba M; Weill A; Coste J; Rudant J
Br J Dermatol; 2019 Jan; 180(1):86-93. PubMed ID: 29791721
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis Trends and Practice Gaps.
Gottlieb AB; Greb JE; Goldminz AM
Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
[TBL] [Abstract][Full Text] [Related]
12. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
Bonafede M; Joseph GJ; Princic N; Harrison DJ
J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
[TBL] [Abstract][Full Text] [Related]
13. Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases.
Han M; Jung YS; Cheon JH; Park S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1166-1174. PubMed ID: 30672608
[TBL] [Abstract][Full Text] [Related]
14. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011.
Armstrong AW; Robertson AD; Wu J; Schupp C; Lebwohl MG
JAMA Dermatol; 2013 Oct; 149(10):1180-5. PubMed ID: 23945732
[TBL] [Abstract][Full Text] [Related]
15. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
16. Management of childhood psoriasis in France. A national survey among general practitioners, pediatricians, and dermatologists.
Mahé E; Bursztejn AC; Phan A; Corgibet F; Beauchet A
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193624
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis.
DI Lernia V; Neri I; Calzavara Pinton P; DI Nuzzo S; Stingeni L; Guarneri C; Belloni Fortina A; Bonamonte D; Cambiaghi S; Lasagni C; Panzone M; Corazza M; Offidani A; Gisondi P
G Ital Dermatol Venereol; 2017 Aug; 152(4):327-332. PubMed ID: 26761766
[TBL] [Abstract][Full Text] [Related]
18. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Piaserico S; Conti A; Lo Console F; De Simone C; Prestinari F; Mazzotta A; Gualdi G; Guarneri C; Borsari S; Cassano N
Acta Derm Venereol; 2014 May; 94(3):293-7. PubMed ID: 24158307
[TBL] [Abstract][Full Text] [Related]
20. Association of Behçet disease with psoriasis and psoriatic arthritis.
Hahn HJ; Kwak SG; Kim DK; Kim JY
Sci Rep; 2021 Jan; 11(1):2531. PubMed ID: 33510251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
